在Loop1中单个氨基酸替换将α-Conotoxin RegIIA的选择性转向α7尼古丁性乙胆受体
Jinpeng Yu1, Junjie Xie1, Yuting Ma1
1Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.
Marine drugs
|September 27, 2024
概括
修改α-毒素规则IIA
科学领域:
- 类化学 类化学
- 神经药理学神经药理学
- 分子生物学分子生物学
背景情况:
- α-Conotoxins是来自牛毒的,具有治疗尼古丁乙胆受体 (nAChR) 相关疾病的潜力.
- 目前的α-conotoxins在nAChR亚型中表现出有限的特异性,阻碍了它们的治疗应用.
研究的目的:
- 通过合成和评估循环1突变物来研究α-conotoxin RegIIA的结构-活性关系.
- 增强RegIIA对特定nAChR亚型,特别是rα7nAChR的功效和选择性.
主要方法:
- α-conotoxin RegIIA的循环1氨基酸替代突变体的合成 RegIIA.
- 对各种nAChR亚型的突变的强度和选择性的电生理学评估.
- 基于初步发现的第二代突变体的设计和合成.
主要成果:
- 氨酸扫描突变物[H5A]RegIIA和[P6A]RegIIA证明了对rα7 nAChR的选择性阻断,对rα3β2和rα3β4亚型的抑制是微不足道的.
- 在循环1中的第五和第六个氨基酸残留被确定为RegIIA的强度和选择性至关重要.
- 第二代突变物[H5V]RegIIA和[H5S]RegIIA对rα7 nAChR.表现出更好的选择性和可比的强度.
结论:
- 循环1中的特定氨基酸替代物显著影响RegIIA与nAChR亚型的相互作用.
- 这项研究为优化α-conotoxins和相关的治疗开发提供了宝贵的见解.
- 有针对性的修改为开发神经系统疾病的选择性nAChR调节器提供了一条途径.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.6K
相关概念视频
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Cholinergic Receptors: Nicotinic
2.5K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Mutations
81.0K
Overview
81.0K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
